1. Xiang, Zhaolan, Zhong, Cheng, Chang, Aoshuang, Zhou, Wei, Zhuo, Xianlu. 2020. Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma. In Aging, 12, 2825-2839. doi:10.18632/aging.102780. https://pubmed.ncbi.nlm.nih.gov/32045884/
2. Onagi, Akifumi, Sugimoto, Kotaro, Kobayashi, Makoto, Kojima, Yoshiyuki, Chiba, Hideki. 2024. Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. In Cell communication and signaling : CCS, 22, 588. doi:10.1186/s12964-024-01964-5. https://pubmed.ncbi.nlm.nih.gov/39639312/
3. Gao, Peipei, Peng, Ting, Cao, Canhui, Yang, Qin, Wu, Peng. 2021. Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family. In Frontiers in genetics, 12, 595436. doi:10.3389/fgene.2021.595436. https://pubmed.ncbi.nlm.nih.gov/34249076/
4. Yang, Wuping, Zhang, Kenan, Zhang, Zedan, Gong, Yanqing, Gong, Kan. 2022. Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by regulating ATP5O and causing mitochondrial dysfunction. In International journal of biological sciences, 18, 2329-2344. doi:10.7150/ijbs.70105. https://pubmed.ncbi.nlm.nih.gov/35414767/
5. Bongers, Ernie M H F, Shelton, Luke M, Milatz, Susanne, Lugtenberg, Dorien, Nijenhuis, Tom. 2017. A Novel Hypokalemic-Alkalotic Salt-Losing Tubulopathy in Patients with CLDN10 Mutations. In Journal of the American Society of Nephrology : JASN, 28, 3118-3128. doi:10.1681/ASN.2016080881. https://pubmed.ncbi.nlm.nih.gov/28674042/
智鼠故事 
